Insights from "EVER-Vilda", Expert Perspective on Vildagliptin's Applicability in Indian T2DM Patients - Video

Published On 2024-03-14T02:45:00+05:30 | Updated On 2 May 2024 2:12 PM IST

Overview

The "EVER-Vilda" opinion paper is an Indian expert's evaluation of the efficacy and rationality of vildagliptin. It underscores vildagliptin's versatile applicability, safety and provides practical guidance for healthcare professionals regarding the use of Vildagliptin in T2DM care.

This expert consensus article has been published in the February 2024 issue of the Journal of Clinical Medicine Insights: Endocrinology and Diabetes.

A panel of 25 experts, including endocrinologists, diabetologists, and cardiologists from India, convened for two advisory board meetings to discuss the various roles and combinations of vildagliptin in managing T2DM.

Some of the final consensus statements include:

1. Vildagliptin 100mg SR OD is a practical therapeutic alternative to 50mg IR BID formulation to improve adherence and persistence.

2. Vildagliptin 100mg SR OD dose is equally effective as 50mg twice daily vildagliptin regarding HBA1c, fasting, and postprandial blood glucose levels.

Adapted from:

1. Kalra S, Zargar AH, Sridhar G, et al. Expert eValuation of Efficacy and Rationality of Vildagliptin “EVER-Vilda”: An Indian Perspective. Clinical Medicine Insights: Endocrinology and Diabetes. 2024;17. doi:10.1177/11795514231203911

Speakers

Dr. Nandita Mohan

BDS, MDS( Pedodontics and Preventive Dentistry)

Dr. Nandita Mohan is a practicing pediatric dentist with more than 5 years of clinical work experience. Along with this, she is equally interested in keeping herself up to date about the latest developments in the field of medicine and dentistry which is the driving force for her to be in association with Medical Dialogues. She also has her name attached with many publications; both national and international. She has pursued her BDS from Rajiv Gandhi University of Health Sciences, Bangalore and later went to enter her dream specialty (MDS) in the Department of Pedodontics and Preventive Dentistry from Pt. B.D. Sharma University of Health Sciences. Through all the years of experience, her core interest in learning something new has never stopped. She can be contacted at editorial@medicaldialogues.in. Contact no. 011-43720751

Dr. Kamal Kant Kohli

Dr Kamal Kant Kohli-MBBS, DTCD- a chest specialist with more than 30 years of practice and a flair for writing clinical articles, Dr Kamal Kant Kohli joined Medical Dialogues as a Chief Editor of Medical News. Besides writing articles, as an editor, he proofreads and verifies all the medical content published on Medical Dialogues including those coming from journals, studies,medical conferences,guidelines etc. Email: drkohli@medicaldialogues.in. Contact no. 011-43720751